The Discounted Cash Flow (DCF) valuation of Cytokinetics Inc (CYTK) is (242.74) USD. With the latest stock price at 69.39 USD, the upside of Cytokinetics Inc based on DCF is -449.8%.
Based on the latest price of 69.39 USD and our DCF valuation, Cytokinetics Inc (CYTK) is a sell. selling CYTK stocks now will result in a potential gain of 449.8%.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| WACC / Discount Rate | 5.4% - 8.6% | 7.0% |
| Long-term Growth Rate | 3.0% - 5.0% | 4.0% |
| Fair Price | (1,732.99) - (136.88) | (242.74) |
| Upside | -2597.5% - -297.3% | -449.8% |